Franklin Resources
PDSB icon

Franklin Resources’s PDS Biotechnology PDSB Stock Holding History

Franklin Resources’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-159,511
Closed -$29.9M – 1541
2017
Q4 		$29.9M Sell
159,511
-103
-0.1% -$20.7K 0.01% 691
2017
Q3 		$34.3M Buy
159,614
+26,458
+20% +$5.47M 0.02% 643
2017
Q2 		$27.3M Buy
133,156
+1,505
+1% +$297K 0.01% 708
2017
Q1 		$24M Buy
131,651
+5,480
+4% +$1.09M 0.01% 736
2016
Q4 		$31.5M Buy
126,171
+1,441
+1% +$327K 0.02% 661
2016
Q3 		$26M Buy
124,730
+5,105
+4% +$1.01M 0.01% 728
2016
Q2 		$24.2M Sell
119,625
-40
-0% -$7.07K 0.01% 754
2016
Q1 		$21.9M Buy
119,665
+4,937
+4% +$883K 0.01% 790
2015
Q4 		$27.1M Buy
+114,728
New +$37M 0.01% 744

Other funds holding PDSB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources's PDSB Position: Q1 2018 in Review

Franklin Resources sold out of PDS Biotechnology (PDSB) in Q1 2018, closing a stake of 159,511 shares — an estimated $29.9M sold.

Franklin Resources first reported a position in PDSB in Q4 2015 and held it in 9 quarters. The position peaked at $34.3M in Q3 2017. 60 funds tracked by Wall St. Rank hold PDSB as of Q1 2018.

  • Franklin Resources reported no remaining PDS Biotechnology position as of Q1 2018 after selling out during the quarter.
  • Franklin Resources sold 159,511 PDS Biotechnology shares in Q1 2018, an estimated $29.9M.
  • Franklin Resources first reported a position in PDS Biotechnology in Q4 2015 and held it in 9 quarters.
  • Franklin Resources's PDS Biotechnology position peaked at $34.3M in Q3 2017.
  • 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2018.

Based on Franklin Resources's 13F filing for Q1 2018, filed 10 May 2018.